Milton Keynes GP on GLP-1 weight-loss pill UK rollout
Dr Adam Staten, 43, a medical director at the private diagnostics clinic hub One Day Tests, said he…
Centre Approves Mounjaro, Ozempic Under CGHS, Warns Against Rule Violations | India News
Last Updated:July 27, 2026, 16:50 IST CGHS have been directed to ensure strict implementation of the guidelines across…
FDA Panel Votes To Ease Restrictions on 6 Peptides—But Experts Still Have Major Concerns
An FDA advisory panel recommended that six investigational peptides be eligible for compounding, but the agency has not…
GLP-1 drugs may slow biological aging, study finds
Weight loss drugs may slow aging process Dr. Suneil Koliwad, Chief of the Division of Endocrinology and Metabolism…
Deadline fast approaching for Canadians to file claim in class-action drug suit
The deadline is fast approaching for Canadians to claim their share of a multimillion-dollar class-action lawsuit over the…
New Cholesterol Pill Lipfendra Now Approved: How It Stacks up to Statins
While tried-and-true high cholesterol treatments like statins are an important way to protect your heart if you have…
Canadians have 1 month left to file claim in class-action drug suit
Listen to this article Estimated 1 minute The audio version of this article is generated by AI-based technology.…
TGA issues warning over GLP-1-based drugs’ potential to cause rare eye disorder
The medicines regulator has issued a new safety warning for GLP-1-based drugs, like Ozempic, which could potentially cause…
Weight loss drugs reduce some employee sick time, a study finds
Savings to the overall health care economy from GLP-1 drugs have yet to be proven, but researchers have…
Canada class-action lawsuit for drug Rexulti: Deadline nears
Updated: July 27, 2026 at 10:01AM EDT Published: July 27, 2026 at 5:32AM EDT The deadline is fast approaching for…
First-in-Class Drug for ADHD Wins FDA Approval
The FDA approved oral centanafadine (Simtriyo), a first-in-class triple reuptake inhibitor for attention deficit-hyperactivity disorder (ADHD), Otsuka announced…
Africa’s most developed pharmaceutical market reviews 12 Ozempic generics as drugmakers target Novo Nordisk’s dominance
The applications could bring more affordable versions of one of the world’s most sought-after medicines into one…